Advances in Modelling and Clinical Application of Intravenous AnaesthesiaJ. Vuyk, Stefan Schraag Since its launch in 1998 the European Society for Intravenous Anaesthesia (EuroSIVA) has come a long way in providing educational material and supporting the research and clinical application of intravenous anaesthesia. After the first two annual meetings held in Barcelona and Amsterdam in 1998 and 1999, three other successful meetings took place in Vienna, Gothenburg and Nice in 2000, 2001 and 2002. Next to these main meetings, starting in the year 2000, a smaller winter meeting has been organised every last week of January in Crans Montana, Switzerland. Both the main summer and the winter meetings breathe the same atmosphere of sharing the latest on intravenous anaesthesia research in the presence of a friendly environment and good company. Since the first meetings the educational tools of EuroSIVA have increased in quantity and technical quality allowing digital slide and video presentation along with the use of the computer simulation program TIVAtrainer during the speaker sessions and the workshops. Furthermore, EuroSIVA now exploits a website www. eurosiva. org that allows for continuous exchange of information on intravenous anaesthesia, the TIVAtrainer, the EuroSIVA meetings and online registration for these meetings. The EuroSIVA is currently engaged in friendly contacts with the Asian Oceanic Society for Intravenous Anaesthesia (AOSIVA), the United Kingdom Society for Intravenous Anaesthesia (UKSIVA), the Korean Society for Intravenous Anaesthesia (KSIVA), the European Society of Anaesthesiology (ESA) and the International Society for Applied Pharmacology (ISAP). |
Contents
BASIC PHARMACOKINETICS PRINCIPLES FOR INTRAVENOUS ANAESTHESIA | 3 |
BASIC CONCEPTS OF RECIRCULATORY PHARMACOKINETIC MODELLING | 19 |
RECIRCULATORY PHARMACOKINETICS WHICH COVARIATES AFFECT THE PHARMACOKINETICS OF INTRAVENOUS ANAESTHETICS? | 27 |
MODELLING OF DRUG INTERACTIONS | 35 |
AGE RELATED CHANGES OF PKPD OF INTRAVENOUS ANAESTHETICS | 45 |
THE CLINICAL APPLICATION OF PHARMACOKINETIC AND DYNAMIC MODELS | 57 |
GENDER DIFFERENCES IN MORPHINE PHARMACOKINETICS AND RESPIRATORY DYNAMICS | 71 |
INFLUENCE OF INTRAVENOUS ANAESTHETICS ON THE CONTROL OF BREATHING | 81 |
SEDATION FOR LOCOREGIONAL ANAESTHESIA | 149 |
TARGET CONTROLLED INFUSION IN CHILDREN | 161 |
REMIFENTAMIL FOR CARDIAC SURGERY | 171 |
EFFECT SITES OF ANALGESIC AND ANAESTHETIC ACTION | 189 |
THE NMDARECEPTOR BEYOND ANAESTHETIC ACTION | 191 |
PHARMACOLOGY AND CLINICAL ACTION OF COX2 SELECTIVE INHIBITORS | 201 |
NEUROMODULATORY ACTION OF ENDOCANNABINOIDS | 215 |
EFFECT SITES OF NEUROMUSCULAR BLOCKING AGENTS AND THE MONITORING OF CLINICAL MUSCLE RELAXATION | 227 |
MONITORING AND CLINICAL APPLICATION OF INTRAVENOUS ANAESTHESIA | 93 |
BISPECTRAL INDEX MONITORING AND INTRAVENOUS ANAESTHESIA | 95 |
AUDITORY EVOKED POTENTIAL MONITORING AS RESEARCH AND CLINICAL TOOL | 105 |
PETSCANNING OF ANAESTHETIC ACTION | 115 |
THE DEVELOPMENT AND FUTURE OF TCI | 123 |
AWARENESS 1960 2002 EXPLICIT RECALL OF EVENTS DURING GENERAL ANAESTHESIA | 135 |
Other editions - View all
Advances in Modelling and Clinical Application of Intravenous Anaesthesia J. Vuyk,Stefan Schraag No preview available - 2012 |
Common terms and phrases
adductor pollicis administration alfentanil anaesthetic agents analgesia analgesic analgesic effect analysis Anesth Analg Anesthesiology Application of Intravenous artery auditory evoked potentials awareness bispectral index blockade blood concentration blood flow bolus bolus dose brain cannabinoid cardiac output celecoxib clearance Clin Clinical Application continuous infusion decrease Diprifusor drug concentration effect compartment effect site concentration effect-site elderly endocannabinoid epidural extubation fentanyl Figure function glutamate haemodynamic hypnotic increase induction infusion rate inhibition inhibitors interaction intraoperative intubation isoflurane ketamine metabolism mg/kg midazolam monitoring morphine neuromuscular neurons ng/ml NMDA receptor opioid parameters parecoxib patients undergoing peak effect peripheral pharmacodynamic pharmacokinetic model pharmacokinetics and pharmacodynamics Pharmacol physiological plasma concentration postoperative pain predict propofol propofol concentration recirculatory model recovery reduced remifentanil response surface rocuronium rofecoxib Schnider Schraag sedation sevoflurane spinal stimulation sufentanil surgical target concentration target controlled infusion TCI systems technique thiopental titration ventilatory response µg/kg/min µg/ml